AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print May 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2006.086256v1
97/7/1228    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerr, T.
Right arrow Articles by Wood, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerr, T.
Right arrow Articles by Wood, E.
Related Collections
Right arrow Health Care Facilities/Services
Right arrow Health Policy
Right arrow HIV/AIDS
Right arrow Surveys
Right arrow Drugs
Right arrow Urban Health
July 2007, Vol 97, No. 7 | American Journal of Public Health 1228-1230
© 2007 American Public Health Association
DOI: 10.2105/AJPH.2006.086256

RESEARCH AND PRACTICE

Circumstances of First Injection Among Illicit Drug Users Accessing a Medically Supervised Safer Injection Facility

Thomas Kerr, PhD, Mark W. Tyndall, MD, ScD, Ruth Zhang, MSc, Calvin Lai, MMath, Julio S.G. Montaner, MD and Evan Wood, PhD

All authors are with the British Columbia Centre for Excellence in HIV/AIDS, Vancouver. Thomas Kerr, Mark W. Tyndall, Julio S.G. Montaner, and Evan Wood are also with the Faculty of Medicine, University of British Columbia, Vancouver.

Correspondence: Requests for reprints should be sent to Thomas Kerr, PhD, BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6 (e-mail: tkerr{at}cfenet.ubc.ca).

There have been concerns that safer injecting facilities may promote initiation into injection drug use. We examined length of injecting career and circumstances surrounding initiation into injection drug use among 1065 users of North America’s first safer injecting facility and found that the median years of injection drug use were 15.9 years, and that only 1 individual reported performing a first injection at the safer injecting facility. These findings indicate that the safer injecting facility’s benefits have not been offset by a rise in initiation into injection drug use.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association